A fresh round of sideways trading continues for OKYO Pharma Limited (OKYO) Stock.

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated 18.75% within the last five trades and 0.59% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 36.80% in the last 6 months and -2.29% was subtracted to its value over the previous 3 months. OKYO stock is trading at a margin of 10.30%, 2.22% and 4.15% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, OKYO deals in the Healthcare domain. The stock is trading -75.57 percent below its 52-week high and 85.85 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -31.9. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

What Does OKYO Pharma Limited’s Profitability and Valuation Ratios Tell Us About the Stock?

The stock’s market cap achieved a total value of $43.64 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 27.83 percent of OKYO Pharma Limited shares are owned by insiders, and 0.42 percent are held by financial institutions. BRANCACCIO JOHN P, the Director at OKYO Pharma Limited (OKYO) has bought 16,670 shares of firm on Sep 15 at a price of $1.50 against the total amount of $25005.0.

Most Popular

Related Posts